GC Cell presented multiple posters from studies of its preclinical study of GL205(GCC2005), a CD5 CAR-NK targeting malignant T-cell lymphoma, and real-world data for the anticancer immunotherapy drug ‘Immuncell-LC’ at the AACR Annual Meeting 2024
If any of the email addresses posted on this website are used to collect unauthorized email addresses through the use of email harvesting programs or other technical devices, the Company through the use of electronic collection programs or other technical devices, and please note that violations of the Information and Communications Network Act are criminally punishable.
GC Cell presented multiple posters from studies of its preclinical study of GL205(GCC2005), a CD5 CAR-NK targeting malignant T-cell lymphoma, and real-world data for the anticancer immunotherapy drug ‘Immuncell-LC’ at the AACR Annual Meeting 2024